secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2026-07-31T20:06:33+00:00
Accession:  0001178913-26-003742
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Amnon Peled resigns from Silexion Therapeutics board effective August 1, 2026
--------------------------------------------------------------------------------

- Professor Amnon Peled resigned from the Board of Directors for personal reasons, effective August 1, 2026.
- Resignation did not result from any disagreement with the Company on operations, policies, or practices.
- No replacement director has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891326003742/0001178913-26-003742-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891326003742/zk2635801.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-003742

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer